Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingjiang Li

Showing results (211-220 of 263) with videos related to

Pageof 27
Sort By:
Journal of Affective Disorders|March 2, 2023
The percentage of cognitive impairment in patients with major depressive disorder over the course of the depression: A longitudinal studyJin Liu, Yanjun Chen, Xinyu Xie, et al.
The Lancet Regional Health. Western Pacific|December 24, 2024
The prevalence and profiles of adverse childhood experiences and their associations with adult mental health outcomes in China: a cross-sectional studyPeilin Xu, Zhaorui Liu, Yifeng Xu, et al.
Psychiatry Research|August 14, 2023
The longitudinal change pattern of cognitive subtypes in medication-free patients with major depressive disorder: a cluster analysisWeilong Guo, Bangshan Liu, Xiyu Wei, et al.
Neuroimage|February 5, 2019
Reproducibility of functional brain alterations in major depressive disorder: Evidence from a multisite resting-state functional MRI study with 1,434 individualsMingrui Xia, Tianmei Si, Xiaoyi Sun, et al.
Journal of Affective Disorders|June 21, 2020
Connectome-based models can predict early symptom improvement in major depressive disorderYumeng Ju, Corey Horien, Wentao Chen, et al.
Frontiers in Psychiatry|December 5, 2019
Exploration of Major Cognitive Deficits in Medication-Free Patients With Major Depressive DisorderJin Liu, Qiangli Dong, Xiaowen Lu, et al.
BMC Medicine|March 4, 2025
Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trialYumeng Ju, Wenwen Ou, Haoran Chen, et al.
Journal of Affective Disorders|May 23, 2021
Functional connectivity evidence for state-independent executive function deficits in patients with major depressive disorderJin Liu, Yumeng Ju, Yiming Fan, et al.
Translational Psychiatry|February 5, 2021
The neuroprogressive nature of major depressive disorder: evidence from an intrinsic connectome analysisJin Liu, Yiming Fan, Ling-Li Zeng, et al.
Frontiers in Psychiatry|August 27, 2025
Prevalence and correlates of anxiety disorders and depressive disorders among older adults with non-communicable diseases: results from China Mental Health SurveyHongmin Ge, Zhaorui Liu, Yue Tong, et al.
Pageof 27

Showing results (211-220 of 263) with videos related to

Sort By:
Pageof 27
Journal of Affective Disorders|March 2, 2023
The percentage of cognitive impairment in patients with major depressive disorder over the course of the depression: A longitudinal studyJin Liu, Yanjun Chen, Xinyu Xie, et al.
The Lancet Regional Health. Western Pacific|December 24, 2024
The prevalence and profiles of adverse childhood experiences and their associations with adult mental health outcomes in China: a cross-sectional studyPeilin Xu, Zhaorui Liu, Yifeng Xu, et al.
Psychiatry Research|August 14, 2023
The longitudinal change pattern of cognitive subtypes in medication-free patients with major depressive disorder: a cluster analysisWeilong Guo, Bangshan Liu, Xiyu Wei, et al.
Neuroimage|February 5, 2019
Reproducibility of functional brain alterations in major depressive disorder: Evidence from a multisite resting-state functional MRI study with 1,434 individualsMingrui Xia, Tianmei Si, Xiaoyi Sun, et al.
Journal of Affective Disorders|June 21, 2020
Connectome-based models can predict early symptom improvement in major depressive disorderYumeng Ju, Corey Horien, Wentao Chen, et al.
Frontiers in Psychiatry|December 5, 2019
Exploration of Major Cognitive Deficits in Medication-Free Patients With Major Depressive DisorderJin Liu, Qiangli Dong, Xiaowen Lu, et al.
BMC Medicine|March 4, 2025
Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trialYumeng Ju, Wenwen Ou, Haoran Chen, et al.
Journal of Affective Disorders|May 23, 2021
Functional connectivity evidence for state-independent executive function deficits in patients with major depressive disorderJin Liu, Yumeng Ju, Yiming Fan, et al.
Translational Psychiatry|February 5, 2021
The neuroprogressive nature of major depressive disorder: evidence from an intrinsic connectome analysisJin Liu, Yiming Fan, Ling-Li Zeng, et al.
Frontiers in Psychiatry|August 27, 2025
Prevalence and correlates of anxiety disorders and depressive disorders among older adults with non-communicable diseases: results from China Mental Health SurveyHongmin Ge, Zhaorui Liu, Yue Tong, et al.
Pageof 27